Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry v3.6.6 is added to the study record history, and the previous entry v3.6.5 is removed. This updates the page's version history to reflect the latest revision.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe record history now includes a new revision entry, v3.6.5. The previous revision, v3.6.4, is removed from the visible history, indicating an administrative update to the record version rather than substantive trial changes.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision entry v3.6.4 was added to the Record History. The prior v3.6.3 entry was removed.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry, v3.6.3, was added to the study's record history. The previous revision, v3.6.2, was removed from the current history view.SummaryDifference0.1%

- Check76 days agoChange DetectedThe Record History shows a new Revision: v3.6.2 entry replacing v3.6.0, representing a new software release for the study record interface.SummaryDifference0.1%

- Check90 days agoChange DetectedThe Version History UI now displays 'Last verified' and 'Last known status was' and adds a 'Revision: v3.6.0' tag, replacing the previous 'Verified', 'Last known status was:', and 'Revision: v3.5.5' indicators. This change updates how revision metadata is presented without modifying the underlying study data.SummaryDifference2%

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.